Valuation: LivaNova PLC

Market Cap 4.49B 3.93B 3.63B 3.33B 6.31B 433B 6.42B 43.3B 16.98B 211B 16.87B 16.5B 729B P/E 2026 *
29.3x
P/E 2027 * 25.4x
Enterprise Value 4.52B 3.95B 3.65B 3.35B 6.34B 435B 6.45B 43.51B 17.07B 212B 16.95B 16.58B 733B EV / Sales 2026 *
2.99x
EV / Sales 2027 * 2.68x
Free-Float
98.44%
Yield 2026 *
-
Yield 2027 * -
1 day+3.00%
1 week-0.87%
Current month-0.54%
1 month+2.62%
3 months+25.56%
6 months+29.44%
Current year+32.93%
1 week 78.07
Extreme 78.07
83.8
1 month 77.71
Extreme 77.71
85.27
Current year 56.44
Extreme 56.44
85.27
1 year 41.02
Extreme 41.015
85.27
3 years 32.48
Extreme 32.48
85.27
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 2024-02-29
Director of Finance/CFO 56 2020-10-30
Investor Relations Contact - 2022-07-31
Director TitleAgeSince
Director/Board Member 66 2020-12-02
Director/Board Member 67 2022-06-12
Director/Board Member 58 2025-09-03
Date Insider Type Main position Quantity % Market Cap.
6/15/26 Fiscal year

Director

10,953 0.0199%
6/15/26 Fiscal year

Executive/Senior Manager

6,962 0.0127%
6/15/26 Fiscal year

Director

12,153 0.0221%
Change 5-day change 1-year change 3-year change Capi.($)
+3.00%-0.87%+88.33%+55.49% 4.36B
+10.71%+3.83%-24.84%-8.43% 155B
+3.84%+1.89%-6.34%-4.67% 103B
+3.85%-0.51%+4.53%+60.90% 57.7B
-1.11%+4.77%+38.09%+52.37% 52.27B
+3.26%+6.22%-10.31%-38.34% 42.68B
+4.23%+2.01% - - 33.35B
+7.22%+5.29%-8.02%-43.21% 28.06B
+0.96%+2.48%+63.96%-5.89% 25.36B
-0.85%+8.07%-4.63%-18.66% 21.03B
Average +2.44%-0.17%+15.64%+5.51% 52.33B
Weighted average by Cap. +2.02%-1.73%-2.08%+2.68%

Financials

2026 *2027 *
Net sales 1.51B 1.32B 1.22B 1.12B 2.12B 145B 2.16B 14.53B 5.7B 70.86B 5.66B 5.54B 245B 1.61B 1.41B 1.31B 1.2B 2.27B 156B 2.31B 15.56B 6.1B 75.85B 6.06B 5.93B 262B
Net income 148M 130M 120M 110M 208M 14.3B 212M 1.43B 561M 6.97B 557M 545M 24.09B 179M 157M 145M 133M 252M 17.29B 256M 1.73B 678M 8.43B 674M 659M 29.13B
Net Debt 22.09M 19.3M 17.86M 16.39M 31.01M 2.13B 31.57M 213M 83.5M 1.04B 82.93M 81.13M 3.59B -165M -144M -133M -122M -231M -15.85B -235M -1.59B -622M -7.73B -618M -604M -26.71B
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
26-07-16 US$81.79 +3.00% 630,900
26-07-15 US$79.41 +0.37% 723,368
26-07-14 US$79.12 -4.65% 828,625
26-07-13 US$82.98 +0.51% 465,972
26-07-10 US$82.56 +0.05% 452,293
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
81.79USD
Average target price
84.80USD
Spread / Average Target
+3.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIVN Stock